Apollomics Inc. (APLM) vs Hyperion DeFi, Inc. (HYPD)

Apollomics Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Apollomics Inc. and Hyperion DeFi, Inc. are of similar size ($68.4M and $64.8M). Apollomics Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 11 metrics below, Apollomics Inc. leads on 8 and Hyperion DeFi, Inc. on 3.

Valuation

Metric APLM HYPD Biotechnology median
P/E n/m n/m 7.88
P/S n/m 40.88 11.47
P/B n/m 0.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 11.46 0.74
EV/Sales n/m 40.02 10.73
Earnings yield (0.27%) (153.22%) (28.84%)
Free cash flow yield 0.00% (134.77%) (23.03%)

Profitability

Metric APLM HYPD Biotechnology median
Gross margin — 78.35% 65.16%
Operating margin — 314.32% 0.00%
Net margin 0.00% (1,224.53%) 0.00%
Free cash flow margin 0.00% (5,509.35%) 0.00%
Return on equity 0.00% (24.63%) (57.72%)
Return on assets 0.00% (20.32%) (49.22%)
Return on invested capital 0.00% 2.73% 0.00%

Growth

Metric APLM HYPD Biotechnology median
Revenue growth (TTM) — 1,990.60% 5.64%
EPS growth (last fiscal year) 85.66% 84.28% —
Revenue growth, 5-year CAGR 32.77% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APLM HYPD Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 0.96 2.34 4.73
Net debt to EBITDA 0.37 (0.03) 0.96

Dividend

Metric APLM HYPD Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric APLM HYPD Biotechnology median
Market cap 68.44m 64.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack